SC 13G Filing

Company

Emergent BioSolutions Inc.

Filed

January 25, 2010

Accession Number

0000906304-10-000112

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →